Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Octreotide, Somatostatin, Pentoxyfilline or Placebo in the Prevention and the Course of Post-ERCP Pancreatitis and Study of Molecular Markers in Post-ERCP Pancreatitis

NCT00222092 is registered in ClinicalTrials.gov with University of Ioannina as lead sponsor.

NCT NCT00222092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00222092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Octreotide, Somatostatin, Pentoxyfilline or Placebo in the Prevention and the Course of Post-ERCP Pancreatitis and Study of Molecular Markers in Post-ERCP Pancreatitis
Lead sponsor
University of Ioannina
Phase
Observational
Overall status
Completed
Start date
September 30, 2005
Completion date
September 30, 2006
Enrollment
300
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp acute pancreatitis